SAN DIEGO, April 28 /PRNewswire-FirstCall/ -- Neurocrine Biosciences, Inc. (Nasdaq:NBIX - News) today announced its financial results for the quarter ended March 31, 2010. For the first quarter of 2010, the Company reported a net loss of $8.6 million, or $0.19 per share compared with a net loss of $19.7 million, or $0.51 per share, for the same period in 2009.
